These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 12888593

  • 1. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.
    Espuelas MS, Legrand P, Campanero MA, Appel M, Chéron M, Gamazo C, Barratt G, Irache JM.
    J Antimicrob Chemother; 2003 Sep; 52(3):419-27. PubMed ID: 12888593
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections.
    Moreno-Rodríguez AC, Torrado-Durán S, Molero G, García-Rodríguez JJ, Torrado-Santiago S.
    Int J Pharm; 2015 Oct 15; 494(1):17-22. PubMed ID: 26256151
    [Abstract] [Full Text] [Related]

  • 3. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system.
    Tabosa Do Egito ES, Appel M, Fessi H, Barratt G, Puisieux F, Devissaguet JP.
    J Antimicrob Chemother; 1996 Sep 15; 38(3):485-97. PubMed ID: 8889723
    [Abstract] [Full Text] [Related]

  • 4. High purity amphotericin B.
    Cleary JD, Chapman SW, Swiatlo E, Kramer R.
    J Antimicrob Chemother; 2007 Dec 15; 60(6):1331-40. PubMed ID: 17921178
    [Abstract] [Full Text] [Related]

  • 5. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.
    Tang X, Zhu H, Sun L, Hou W, Cai S, Zhang R, Liu F.
    Int J Nanomedicine; 2014 Dec 15; 9():5403-13. PubMed ID: 25473279
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of renal toxicity and antifungal activity of free and liposomal amphotericin B following a single intravenous dose to diabetic rats with systemic candidiasis.
    Wasan KM, Conklin JS.
    Antimicrob Agents Chemother; 1996 Aug 15; 40(8):1806-10. PubMed ID: 8843285
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of alternative dosing regimens of poly-aggregated amphotericin B.
    Espada R, Valdespina S, Molero G, Dea MA, Ballesteros MP, Torrado JJ.
    Int J Antimicrob Agents; 2008 Jul 15; 32(1):55-61. PubMed ID: 18534826
    [Abstract] [Full Text] [Related]

  • 8. In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating.
    Petit C, Chéron M, Joly V, Rodrigues JM, Bolard J, Gaboriau F.
    J Antimicrob Chemother; 1998 Dec 15; 42(6):779-85. PubMed ID: 10052902
    [Abstract] [Full Text] [Related]

  • 9. In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments.
    Lincopan N, Mamizuka EM, Carmona-Ribeiro AM.
    J Antimicrob Chemother; 2003 Sep 15; 52(3):412-8. PubMed ID: 12917237
    [Abstract] [Full Text] [Related]

  • 10. Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B.
    Oda MN, Hargreaves PL, Beckstead JA, Redmond KA, van Antwerpen R, Ryan RO.
    J Lipid Res; 2006 Feb 15; 47(2):260-7. PubMed ID: 16314670
    [Abstract] [Full Text] [Related]

  • 11. Antifungal Efficacy of an Intravenous Formulation Containing Monomeric Amphotericin B, 5-Fluorocytosine, and Saline for Sodium Supplementation.
    Alvarez C, Andes DR, Kang JY, Krug C, Kwon GS.
    Pharm Res; 2017 May 15; 34(5):1115-1124. PubMed ID: 28205003
    [Abstract] [Full Text] [Related]

  • 12. Comparative therapeutic efficacy of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and deoxycholate-amphotericin B in immunocompetent and neutropenic mice infected with Candida albicans.
    Brime B, Molero G, Frutos P, Frutos G.
    Eur J Pharm Sci; 2004 Aug 15; 22(5):451-8. PubMed ID: 15265515
    [Abstract] [Full Text] [Related]

  • 13. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
    Moraes Moreira Carraro TC, Altmeyer C, Maissar Khalil N, Mara Mainardes R.
    J Mycol Med; 2017 Dec 15; 27(4):519-529. PubMed ID: 28797532
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN, Adhikari K, Srichana T.
    Int J Pharm; 2014 Aug 25; 471(1-2):430-8. PubMed ID: 24907597
    [Abstract] [Full Text] [Related]

  • 15. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
    Espada R, Valdespina S, Dea MA, Molero G, Ballesteros MP, Bolás F, Torrado JJ.
    J Antimicrob Chemother; 2008 May 25; 61(5):1125-31. PubMed ID: 18285313
    [Abstract] [Full Text] [Related]

  • 16. Preparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral Candida albicans.
    Zhou L, Zhang P, Chen Z, Cai S, Jing T, Fan H, Mo F, Zhang J, Lin R.
    Int J Nanomedicine; 2017 May 25; 12():4269-4283. PubMed ID: 28652732
    [Abstract] [Full Text] [Related]

  • 17. Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects.
    Charvalos E, Tzatzarakis MN, Van Bambeke F, Tulkens PM, Tsatsakis AM, Tzanakakis GN, Mingeot-Leclercq MP.
    J Antimicrob Chemother; 2006 Feb 25; 57(2):236-44. PubMed ID: 16361329
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological parameters of intravenously administered amphotericin B in rats: comparison of the conventional formulation with amphotericin B associated with a triglyceride-rich emulsion.
    Souza LC, Campa A.
    J Antimicrob Chemother; 1999 Jul 25; 44(1):77-84. PubMed ID: 10459813
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.
    Andes D, Safdar N, Marchillo K, Conklin R.
    Antimicrob Agents Chemother; 2006 Feb 25; 50(2):674-84. PubMed ID: 16436726
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.
    Groll AH, Giri N, Petraitis V, Petraitiene R, Candelario M, Bacher JS, Piscitelli SC, Walsh TJ.
    J Infect Dis; 2000 Jul 25; 182(1):274-82. PubMed ID: 10882607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.